Most cases of autosomal dominant polycystic kidney disease (ADPKD) are caused by mutations in PKD1, which reduce polycystin-1 (PC1) levels below a critical functional threshold. Normalizing PC1 dosage mitigates disease progression; therefore, we sought to develop a CRISPR activation (CRISPRa) strategy to transcriptiona...
Anubhav Chakraborty, Meekha M. Varghese, Darren P. Wallace et al.· AJP - Renal Physiology· 0 citations
A disruption in ferritin handling and iron homeostasis in PKD is demonstrated, suggesting altered iron trafficking promotes localized oxidative stress and fibrosis contributing to disease progression.
Nicole Sommer, Sagine Placide, Elizabeth Weatherly et al.· AJP - Renal Physiology· 0 citations
Findings reveal that autophagy in MFs is a previously unrecognized driver of cyst expansion and fibrosis in ADPKD and targeting MF-specific autophagy or its upstream regulators may represent a therapeutic strategy to limit cyst growth and fibrosis in ADPKD.
Abeda Jamadar, Viji Remadevi, Meekha M. Varghese et al.· Cell communication and signa...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.